Kestra Medical Technologies reported an insider sale worth $2,408,590 on October 30, 2026. It changes the insider's holdings, but the report gives no change in the company's business or performance to alter its outlook.
The sale changes what the insider owns, not the company's products, sales, or cash. The report gives no reason for the sale and mentions no change in company performance, so it does not change the outlook.
Follow Kestra Medical Technologies, Ltd. (KMTS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for KMTS